Citi Analysts Respond To Recent Monsanto Deal Talk


27% profit every 20 days?

This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.


Citi, in a note to clients dated July 14, said although Bayer AG (ADR)

ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

(OTC: BAYRY) has increased its offer for Monsanto Company (NYSE: MON), "it may still fall short of expectations."

Bayer raised its offer to acquire Monsanto, one of the biggest seed makers, by $3 to $125 a share, representing a 15.6x multiple on MON's 2017E EBITDA. In addition, Bayer is offering Monsanto a $1.5 billion reverse break free should the deal be blocked by regulators.

Other Possibilities?

Meanwhile, Bloomberg reported that Monsanto and BASF SE (ADR) (OTC: BASFY) have resumed talks regarding a potential acquisition of BASF's Ag chemical business.


FREE REPORT: How To Learn Options Trading Fast

In this special report, you will learn the four best strategies for trading options, how to stay safe as a complete beginner, ​a 411% trade case study, PLUS how to access two new potential winning options trades starting today.Claim Your Free Report Here.


"We think that this was one of the potential 'other options' MON management hinted at on their 3Q conference call. Given the outstanding offer by Bayer to acquire MON, it is difficult to glean whether this type of transaction has potential, or if this is posturing," Citi analyst P.J. Juvekar wrote in the note.

"Further, it is unclear to us that BASF is a willing seller in this market, although we have discussed the potential of a JV in the past. BASF may be interested in being an acquirer of assets which may be divested during this round of Ag industry consolidation," Juvekar continued.

Juvekar noted that if Monsanto makes a takeout offer for BASF's Ag business, it would likely result in a transaction value in the range of approximately $22 billion–$25 billion, based on forward EBITDA multiples of roughly 14–15x, a discount to the Bayer offer for Monsanto. Citi expects BASF 2017 Ag EBITDA near $1.6 billion.

Citi's Bottom Line

"We think BASF's business would be valued at a discount to MON because it does not have seeds. Any transaction would be third in the queue for regulatory approval behind Syngenta-ChemChina and DOW-DuPont," Juvekar added.

Juvekar has a Neutral rating and $112 price target on Monsanto stock.

Shares of Monsanto closed Friday's regular trading session at $103.45, while ADRs of Bayer closed at $103.70.

Did you like this article? Could it have been improved? Please email feedback@benzinga.com with the story link to let us know!

27% profit every 20 days?

This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.


Posted In: Analyst ColorNewsPrice TargetCommoditiesReiterationM&AMarketsAnalyst RatingsBloombergCiti